SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 116 filers reported holding SUTRO BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is 2.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $124,826 | -10.7% | 35,973 | +19.7% | 0.00% | – |
| Q2 2023 | $139,798 | -63.4% | 30,064 | -63.6% | 0.00% | – |
| Q1 2023 | $382,074 | -34.9% | 82,700 | +13.8% | 0.00% | – |
| Q4 2022 | $587,117 | +9685.3% | 72,663 | +6659.3% | 0.00% | – |
| Q3 2022 | $6,000 | -68.4% | 1,075 | -71.1% | 0.00% | – |
| Q2 2022 | $19,000 | -97.9% | 3,723 | -96.6% | 0.00% | – |
| Q1 2022 | $907,000 | +3843.5% | 110,333 | +8936.3% | 0.00% | – |
| Q3 2021 | $23,000 | +91.7% | 1,221 | +140.8% | 0.00% | – |
| Q1 2021 | $12,000 | +50.0% | 507 | -32.6% | 0.00% | – |
| Q3 2020 | $8,000 | -81.0% | 752 | -86.0% | 0.00% | – |
| Q2 2020 | $42,000 | -38.2% | 5,375 | -18.9% | 0.00% | – |
| Q1 2020 | $68,000 | -54.1% | 6,628 | -50.8% | 0.00% | – |
| Q4 2019 | $148,000 | +87.3% | 13,464 | +54.9% | 0.00% | – |
| Q3 2019 | $79,000 | +259.1% | 8,690 | +341.1% | 0.00% | – |
| Q2 2019 | $22,000 | -35.3% | 1,970 | -47.6% | 0.00% | – |
| Q4 2018 | $34,000 | +78.9% | 3,758 | +201.1% | 0.00% | – |
| Q3 2018 | $19,000 | – | 1,248 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,675,579 | $5,814,259 | 1.78% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,883,693 | $20,416,415 | 1.10% |
| Kynam Capital Management, LP | 1,552,675 | $5,387,782 | 0.88% |
| Parkman Healthcare Partners LLC | 1,182,168 | $4,102,123 | 0.75% |
| Rubric Capital Management LP | 3,344,810 | $11,606,491 | 0.44% |
| BVF INC/IL | 3,347,946 | $11,617,373 | 0.31% |
| DAFNA Capital Management LLC | 283,079 | $982,284 | 0.31% |
| SECTORAL ASSET MANAGEMENT INC | 432,339 | $1,500,216 | 0.29% |
| Eversept Partners, LP | 769,638 | $2,670,644 | 0.23% |
| Frazier Life Sciences Management, L.P. | 780,000 | $2,706,600 | 0.18% |